• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖抗原 125、糖抗原 15-3 和低密度脂蛋白作为绝经后乳腺癌眼内转移的危险因素。

Carbohydrate antigen 125, carbohydrate antigen 15-3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer.

机构信息

Department of Oncology, the Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou, Hunan, China.

Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.

出版信息

Medicine (Baltimore). 2021 Oct 29;100(43):e27693. doi: 10.1097/MD.0000000000027693.

DOI:10.1097/MD.0000000000027693
PMID:34713867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8556018/
Abstract

The prognosis of patients with postmenopausal breast cancer (PBC) could be improved by the early detection of intraocular metastases (IOMs). However, serum biomarkers for IOMs in PBC remain elusive. In the current study, we investigated patients with PBC, and compared serum parameters in an IOM and a non-IOM group, and then differentiated the risk factors related to IOMs. A comparison between an IOM and a non-IOM (NIOM) group was performed using Student t-test and a Chi-Squared test. After constructing a Poisson regression model to identify risk factors, we plotted receiver operating characteristic curves to evaluate the predictive value of significant risk factors in detecting IOMs. The incidence of IOMs in PBC was 1.16%. The histopathology results were not significantly different between the 2 groups. The levels of serum carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and alkaline phosphatase were significantly elevated in IOMs compared with NIOMs (P = .082, P < .001, and P < .001, respectively). Compared with NIOMs, age, carbohydrate antigen 19 to 9, hemoglobin, calcium, total cholesterol, low-density lipoprotein (LDL) and apolipoprotein A1 were remarkably lower in IOMs (P = .038, P < .001, P < .001, P = .032, P = .041, P < .001, and P = .001, respectively). Poisson regression suggested that CA-125, CA15-3 and LDL were contributing to IOMs in PBC as risk factors (OR = 1.003, 95% CI: 1.001-1.005; OR = 1.025, 95% CI: 1.019-1.033; OR = 0.238, 95% CI: 0.112-0.505, respectively). A receiver operating characteristic curve revealed that the cut-off values for CA-125, CA15-3 and LDL were 16.78 0 U/mL, 63.175 U/mL, and 2.415 mmol/L, respectively. The combination of CA-125 and CA15-3 showed significant diagnostic value (area under the curve [AUC] = 0.982, P < .001). Our investigation suggests that CA-125, CA15-3 and LDL remarkably predict IOMs in PBC as risk factors, and the combination of CA-125 and CA15-3 shows considerable diagnostic value.

摘要

患有绝经后乳腺癌(PBC)的患者通过早期发现眼内转移(IOM)可以改善预后。然而,PBC 患者的 IOM 血清生物标志物仍然难以捉摸。在本研究中,我们研究了患有 PBC 的患者,并比较了 IOM 组和非 IOM 组的血清参数,然后区分了与 IOM 相关的危险因素。使用学生 t 检验和卡方检验对 IOM 组和非 IOM(NIOM)组进行比较。在构建识别危险因素的泊松回归模型后,我们绘制了受试者工作特征曲线,以评估显著危险因素在检测 IOM 中的预测价值。PBC 患者 IOM 的发生率为 1.16%。两组的组织病理学结果无显着差异。与 NIOM 相比,IOM 中血清糖抗原 125(CA-125)、糖抗原 15-3(CA15-3)和碱性磷酸酶的水平显着升高(P=0.082,P<0.001 和 P<0.001,分别)。与 NIOM 相比,IOM 中的年龄、肿瘤标志物 19-9、血红蛋白、钙、总胆固醇、低密度脂蛋白(LDL)和载脂蛋白 A1 显着降低(P=0.038,P<0.001,P<0.001,P=0.032,P=0.041,P<0.001 和 P=0.001,分别)。泊松回归表明,CA-125、CA15-3 和 LDL 是 PBC 中 IOM 的危险因素(OR=1.003,95%CI:1.001-1.005;OR=1.025,95%CI:1.019-1.033;OR=0.238,95%CI:0.112-0.505,分别)。受试者工作特征曲线显示,CA-125、CA15-3 和 LDL 的截断值分别为 16.780 U/mL、63.175 U/mL 和 2.415 mmol/L。CA-125 和 CA15-3 的组合具有显著的诊断价值(曲线下面积[AUC]=0.982,P<0.001)。我们的研究表明,CA-125、CA15-3 和 LDL 显着预测 PBC 中的 IOM 作为危险因素,CA-125 和 CA15-3 的组合具有相当大的诊断价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8556018/882307e1d920/medi-100-e27693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8556018/21614ab208b2/medi-100-e27693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8556018/882307e1d920/medi-100-e27693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8556018/21614ab208b2/medi-100-e27693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cb/8556018/882307e1d920/medi-100-e27693-g002.jpg

相似文献

1
Carbohydrate antigen 125, carbohydrate antigen 15-3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer.糖抗原 125、糖抗原 15-3 和低密度脂蛋白作为绝经后乳腺癌眼内转移的危险因素。
Medicine (Baltimore). 2021 Oct 29;100(43):e27693. doi: 10.1097/MD.0000000000027693.
2
Apolipoprotein A1 and Low-Density Lipoprotein as Risk Factors for Intraocular Metastases in Postmenopausal Breast Cancer.载脂蛋白 A1 和低密度脂蛋白作为绝经后乳腺癌眼内转移的危险因素。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820984180. doi: 10.1177/1533033820984180.
3
Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.CA-153 和 CYFRA 21-1 对预测转移性肺癌患者眼内转移的诊断价值。
Cancer Med. 2020 Feb;9(4):1279-1286. doi: 10.1002/cam4.2354. Epub 2019 Jun 20.
4
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.血清肿瘤标志物癌胚抗原(CEA)、糖类抗原19-9(CA19-9)、糖类抗原125(CA125)、糖类抗原15-3(CA15-3)及组织多肽特异性抗原(TPS)在转移性乳腺癌中的诊断价值
Clin Chim Acta. 2017 Jul;470:51-55. doi: 10.1016/j.cca.2017.04.023. Epub 2017 Apr 27.
5
Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer.术前血清 CEA 和 CA15-3 水平与乳腺癌分子亚型的关系。
Dis Markers. 2021 Sep 27;2021:5529106. doi: 10.1155/2021/5529106. eCollection 2021.
6
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.术前血清癌胚抗原和癌抗原 15-3 水平对早期乳腺癌亚型的独立预后影响。
World J Surg Oncol. 2018 Feb 12;16(1):26. doi: 10.1186/s12957-018-1325-6.
7
Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population.评估血清微小RNA-21和微小RNA-205作为印度人群I期和II期乳腺癌诊断标志物的价值。
Indian J Cancer. 2024 Apr 1;61(2):290-298. doi: 10.4103/ijc.IJC_187_20. Epub 2023 Jul 17.
8
[Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].[血清Ca 15-3抗原升高:乳腺癌远处转移的早期指标。733例回顾性分析]
Przegl Lek. 2001;58(6):498-503.
9
Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.评估血清CA-125、CA15-3、CA-19-9、癌胚抗原和甲胎蛋白水平对于鉴别附件肿块良恶性的重要性以及不同检测组合对诊断准确性的贡献。
Eur J Gynaecol Oncol. 2013;34(6):540-4.
10
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.基于LOCI™技术的肿瘤标志物检测法对妇科癌症中肿瘤标志物CA 15-3、CA 125、癌胚抗原(CEA)、CA 19-9和甲胎蛋白(AFP)的临床检测性能
Tumour Biol. 2017 Oct;39(10):1010428317730246. doi: 10.1177/1010428317730246.

引用本文的文献

1
Integrative approach for enhanced ovarian cancer diagnosis: cytology and biomarkers.用于增强卵巢癌诊断的综合方法:细胞学与生物标志物
Discov Oncol. 2025 Aug 10;16(1):1519. doi: 10.1007/s12672-025-03231-6.
2
Utility of CA-125 for diagnosis and prognosis of breast cancer: a systematic review.CA-125在乳腺癌诊断和预后中的应用:一项系统评价。
Explor Target Antitumor Ther. 2025 May 15;6:1002316. doi: 10.37349/etat.2025.1002316. eCollection 2025.